{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:26:41Z","timestamp":1791052001123,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1097\/01.qai.0000192005.08153.a3","type":"journal-article","created":{"date-parts":[[2006,1,4]],"date-time":"2006-01-04T09:01:35Z","timestamp":1136365295000},"page":"180-185","source":"Crossref","is-referenced-by-count":25,"title":["Influence of Genotype 3 Hepatitis C Coinfection on Liver Enzyme Elevation in HIV-1-Positive Patients After Commencement of a New Highly Active Antiretroviral Regimen"],"prefix":"10.1097","volume":"41","author":[{"given":"Carlo","family":"Torti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Puoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Casari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Uccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Cristini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Ladisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Minoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Lo","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Carosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210131","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00002030-200203290-00009","article-title":"Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort.","volume":"16","author":"Dieleman","year":"2002","journal-title":"AIDS"},{"key":"R2-9-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00042560-200201010-00005","article-title":"Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection.","volume":"29","author":"Aceti","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-9-20210131","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1097\/00002030-200012220-00011","article-title":"Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.","volume":"14","author":"den Brinker","year":"2000","journal-title":"AIDS"},{"key":"R4-9-20210131","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/00002030-199810000-00025","article-title":"Hepatotoxicity after introduction of highly active antiretroviral therapy.","volume":"12","author":"Rodriguez-Rosado","year":"1998","journal-title":"AIDS"},{"key":"R5-9-20210131","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"R6-9-20210131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/341084","article-title":"Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.","volume":"186","author":"Wit","year":"2002","journal-title":"J Infect Dis"},{"key":"R7-9-20210131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jhep.2004.11.017","article-title":"Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era.","volume":"42","author":"Kramer","year":"2005","journal-title":"J Hepatol"},{"key":"R8-9-20210131","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jhep.2004.12.011","article-title":"Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.","volume":"42","author":"Nunez","year":"2005","journal-title":"J Hepatol"},{"key":"R9-9-20210131","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00126334-200110010-00002","article-title":"Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.","volume":"28","author":"Monforte","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-9-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00042560-200205010-00008","article-title":"Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy.","volume":"30","author":"Nunez","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-9-20210131","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1310\/2L6M-EE7G-5PGN-FJYP","article-title":"Acute liver enzyme elevations in HIV-1-infected patients.","volume":"4","author":"Livry","year":"2003","journal-title":"HIV Clin Trials"},{"key":"R13-9-20210131","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.","volume":"33","author":"Adinolfi","year":"2001","journal-title":"Hepatology"},{"key":"R14-9-20210131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2003.08.007","article-title":"Hepatitis C virus infection and liver steatosis.","volume":"60","author":"Ramalho","year":"2003","journal-title":"Antiviral Res"},{"key":"R15-9-20210131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/B:DDAS.0000011597.92851.56","article-title":"Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?","volume":"49","author":"Sharma","year":"2004","journal-title":"Dig Dis Sci"},{"key":"R16-9-20210131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.","volume":"33","author":"Rubbia-Brandt","year":"2000","journal-title":"J Hepatol"},{"key":"R17-9-20210131","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2893.2004.00528.x","article-title":"Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.","volume":"11","author":"Hezode","year":"2004","journal-title":"J Viral Hepat"},{"key":"R18-9-20210131","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0399-8320(04)94918-4","article-title":"Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.","volume":"28","author":"Cholet","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"R19-9-20210131","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.2003.018770","article-title":"Steatosis affects chronic hepatitis C progression in a genotype specific way.","volume":"53","author":"Rubbia-Brandt","year":"2004","journal-title":"Gut"},{"key":"R20-9-20210131","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0168-8278(02)00299-4","article-title":"Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.","volume":"37","author":"Westin","year":"2002","journal-title":"J Hepatol"},{"key":"R21-9-20210131","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.aids.0000163935.99401.25","article-title":"Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.","volume":"19","author":"Sulkowski","year":"2005","journal-title":"AIDS"},{"key":"R22-9-20210131","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/427216","article-title":"Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.","volume":"40","author":"Aranzabal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R24-9-20210131","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2004.02.002","article-title":"Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses.","volume":"40","author":"Hultgren","year":"2004","journal-title":"J Hepatol"},{"key":"R25-9-20210131","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/hep.20706","article-title":"T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C.","volume":"41","author":"Kaplan","year":"2005","journal-title":"Hepatology"},{"key":"R26-9-20210131","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/341659","article-title":"CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.","volume":"186","author":"Legrand","year":"2002","journal-title":"J Infect Dis"},{"key":"R27-9-20210131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2334-5-58","article-title":"Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.","volume":"5","author":"Torti","year":"2005","journal-title":"BMC Infect Dis"},{"key":"R28-9-20210131","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1097\/00002030-200411190-00008","article-title":"Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.","volume":"18","author":"Sulkowski","year":"2004","journal-title":"AIDS"},{"key":"R29-9-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-200401020-00001","article-title":"Care of patients with hepatitis C and HIV co-infection.","volume":"18","author":"Soriano","year":"2004","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007435-200605000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:23:43Z","timestamp":1618280623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200602010-00009"}},"subtitle":["Results From the EPOKA-MASTER Cohort"],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.qai.0000192005.08153.a3","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}